SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Biotechnology

Healthcare
$29.68 +2.49%

+$0.45 today

Market cap
$993.14M
Beta
-0.34
P/E (TTM)
-14.1
EPS (TTM)
-$1.32
52W Low $17.06High $32.44

Volume 0.10M

Average 0.09M

SGP Capital Expenditures

Cash spent on property, plant, equipment, and other long-term assets.

SpyGlass Pharma, Inc. Common StockNASDAQ: SGP

Capital Expenditures · Q1 FY2026 · quarter ended Mar 2026

Capital expenditures of -$676K in Q1 FY2026

Q1 FY2026 capital expenditures was -$676K.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
-$676K+60.8% QoQ
Last fiscal yearDec 2025
-$789K— YoY
Capital Expenditures past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter———
1 year———
3-year CAGR———
5-year CAGR——
10-year CAGR——

Capital Expenditures history

USD · from the cash flow

Latest · FY2025
(789K) USD
Year-over-year change
—

Capital Expenditures vs competitors

How SGP compares with its peers on the latest reported figures

  • Peers report in different currencies, so capital expenditures is compared through growth and share of revenue rather than absolute size.
SGP Competitors
Capital Expenditures for SGP and competitors
Company Period LTM YoY 3-year CAGR% of revenue
ALCAlcon Inc.LTM Sep 2026$582.3M USD-0.1%-3.8%5.3%
BLCOBausch + Lomb CorporationLTM Jun 2026$318.06M USD-9.4%+25.9%6.0%
OCULOcular Therapeutix, Inc.LTM Mar 2026$14.74M USD+396.9%+47.9%28.3%
GKOSGlaukos CorporationLTM Jun 2026$11.25M USD+78.5%-36.7%1.8%
STAASTAAR Surgical CompanyLTM Apr 2026$4.8M USD+140.8%-31.5%1.7%
RXSTRxSight, Inc.LTM Mar 2026$4.01M USD-0.8%+17.0%3.1%
EYPTEyePoint Pharmaceuticals, Inc.LTM Mar 2026$4M USD+27.7%+15.1%52.5%
SGPSpyGlass Pharma, Inc. Common StockFY2025$789K USD———
OCSOculis Holding AGLTM Mar 2026CHF 294.17K CHF-77.9%-56.7%58.4%
SGHTSight Sciences, Inc.LTM Mar 2026$284K USD+6.0%-38.6%0.4%
Peer median (excluding SGP) —+6.0%-3.8%5.3%

Competitors are the stored peer set for SGP. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

SpyGlass Pharma, Inc. Common Stock

NASDAQ:SGP

Intrinsic Alpha fair value

Locked

Current Price

$29.68

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.